drugset / Trial / NCT07004296
A Study of HDM2005 in Patients With Advanced Solid Tumor
NaSequentialOpen-labelTreatment
Summary
This is a study evaluating the efficacy, safety, and pharmacokinetics ofHDM2005 in participants with metastatic solid tumors.
Timeline
- Start
- 2025-05-29
- Primary completion
- 2027-07-01
- Completion
- 2027-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HDM2005 | Unknown | 1.2 mg/kg | Intravenous |
| Subject | HDM2005 | Unknown | 1.8 mg/kg | Intravenous |
| Subject | HDM2005 | Unknown | 2 mg/kg | Intravenous |
| Subject | HDM2005 | Unknown | 2.5 mg/kg | Intravenous |